Exact Sciences reports Q3 results that beat Wall Street expectations
ASSOCIATED PRESS, STATE JOURNAL STAFF
Updated
Researchers at Exact Sciences and UW-Madison are working on "liquid biopsies" for cancer, including blood tests that identify genetic mutations in tumors targeted by drugs. The tests also might track whether cancer has returned after treatment and detect early disease. Research associate Alycia Riehl runs tests on samples at Exact Sciences.
Emilie Heidemann picks her 5 favorite 2021 stories
One of the first stories I wrote this year for the Wisconsin State Journal wasn't published last January, but instead at the beginning of September — when I officially took my post as business reporter.
It was about a biotech startup that won the Greater Madison Chamber of Commerce's Pressure Chamber contest for the novel ways it was looking to prevent cancer — and a coronavirus infection. The week I wrote that piece was when I discovered the treasure trove of story ideas that made up Madison's business community.
Researchers at Exact Sciences and UW-Madison are working on "liquid biopsies" for cancer, including blood tests that identify genetic mutations in tumors targeted by drugs. The tests also might track whether cancer has returned after treatment and detect early disease. Research associate Alycia Riehl runs tests on samples at Exact Sciences.
